# SEvoflurane for Sedation in ARds

> **NCT04235608** · PHASE3 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 700 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Inhaled sedation with sevoflurane
- **DRUG:** intravenous sedation with propofol

## Key facts

- **NCT ID:** NCT04235608
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-03
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-10-02
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04235608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04235608, "SEvoflurane for Sedation in ARds". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04235608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*